Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Cognition Therapeutics Inc Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $4.37 Billion
- Q2 2025
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 48,000 shares of CGTX stock, worth $39,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,000Holding current value
$39,360% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
57Shares Held
13.9MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$4.92 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.81 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$1.02 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.01MShares$826,2200.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$498,8790.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $18.6M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...